Trimethyl-[5-methyl-3-propan-2-ylidene-4-(2-trimethylsilylethynyl)hex-4-en-1-ynyl]silane
C18H30Si2 — CID 154721354
Data last refreshed: (MolForge compound catalog, from PubChem)
About Trimethyl-[5-methyl-3-propan-2-ylidene-4-(2-trimethylsilylethynyl)hex-4-en-1-ynyl]silane
Trimethyl-[5-methyl-3-propan-2-ylidene-4-(2-trimethylsilylethynyl)hex-4-en-1-ynyl]silane (PubChem CID 154721354) has the molecular formula C18H30Si2 and a molecular weight of 302.61 g/mol. Its IUPAC name is trimethyl-[5-methyl-3-propan-2-ylidene-4-(2-trimethylsilylethynyl)hex-4-en-1-ynyl]silane.
Molecular Properties
| Compound Name | Trimethyl-[5-methyl-3-propan-2-ylidene-4-(2-trimethylsilylethynyl)hex-4-en-1-ynyl]silane |
|---|---|
| PubChem CID | 154721354 |
| Molecular Formula | C18H30Si2 |
| Molecular Weight | 302.61 g/mol |
| Exact Mass | 302.19 |
| IUPAC Name | trimethyl-[5-methyl-3-propan-2-ylidene-4-(2-trimethylsilylethynyl)hex-4-en-1-ynyl]silane |
| SMILES | CC(C)=C(C#C[Si](C)(C)C)C(C#C[Si](C)(C)C)=C(C)C |
| InChI | InChI=1S/C18H30Si2/c1-15(2)17(11-13-19(5,6)7)18(16(3)4)12-14-20(8,9)10/h1-10H3 |
| InChIKey | LIARLWFOQXEYJI-UHFFFAOYSA-N |
| XLogP | 5.42 |
| TPSA | 0.00 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | |
| Rotatable Bonds | 1 |
| Heavy Atoms | 20 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 302.61 |
| LogP ≤ 5 | 5.42 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 0 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'polyene', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154721354 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.